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ABSTRACT: Antifreeze proteins and glycoproteins [AF(G)Ps] have been well-known for more than three decades for their
ability to inhibit the growth and recrystallization of ice through binding to specific ice crystal faces, and they show remarkable
structural compatibility with specific ice crystal faces. Here, we show that the crystal growth faces of methyl α-D-
mannopyranoside (MDM), a representative pyranose sugar, also show noteworthy structural compatibility with the known
periodicities of AF(G)Ps. We selected fish AFGPs (AFGP8, AFGP1−5), and a beetle AFP (DAFP1) with increasing antifreeze
activity as potential additives for controlling MDM crystal growth. Similar to their effects on ice growth, the AF(G)Ps can inhibit
MDM crystal growth and recrystallization, and more significantly, the effectiveness for the AF(G)Ps are well correlated with their
antifreeze activity. MDM crystals grown in the presence of AF(G)Ps are smaller and have better defined shapes and are of higher
quality as indicated by single crystal X-ray diffraction and polarized microscopy than control crystals, but no new polymorphs of
MDM were identified by single crystal X-ray diffraction, solid-state NMR, and attenuated total reflectance infrared spectroscopy.
The observed changes in the average sizes of the MDM crystals can be related to the changes in the number of the MDM nuclei
in the presence of the AF(G)Ps. The critical free energy change differences of the MDM nucleation in the absence and presence
of the additives were calculated. These values are close to those of the ice nucleation in the presence of AF(G)Ps suggesting
similar interactions are involved in the molecular recognition of MDM by the AF(G)Ps. To our knowledge this is the first report
where AF(G)Ps have been used to control crystal growth of carbohydrates and on AFGPs controlling non-ice-like crystals. Our
finding suggests MDM might be a possible alternative to ice for studying the detailed mechanism of AF(G)P−crystal
interactions. The relationships between AF(G)Ps and carbohydrate binding proteins are also discussed. The structural
compatibility between AF(G)Ps and growing crystal faces demonstrated herein adds to the repertoire of molecular recognition
by AF(G)Ps, which may have potential applications in the sugar, food, pharmaceutical, and materials industries.
■ INTRODUCTION
Antifreeze proteins and antifreeze glycoproteins [AF(G)Ps] are
defined by their ability to inhibit the growth and recrystalliza-
tion of ice by binding to specific ice crystal surfaces.1−3
AF(G)Ps have diverse structures. For examples, AFGPs (e.g.,
AFGP1−5, AFGP8) found in the blood of the Antarctic fish
Pagothenia borchgrevinki consist of glycotripeptide repeats (Ala-
Ala-Thr), where the disaccharide, β-D-galactosyl(1 → 3)-α-N-
acetylgalactosamine, is joined to each threonine through a
glycosidic linkage. AFP isoform 1 isolated from the hemolymph
of the beetle Dendroides canadensis (DAFP1) is composed of
12- or 13-mer repeats including Thr-Xxx-Thr (where Xxx is any
amino acid) without glycosylation (Figure 1). AF(G)Ps also
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possess different antifreeze activities. The difference between
the melting point and the noncolligative freezing point of H2O
in the presence of AF(G)Ps is referred to as thermal hysteresis
(TH), the value of which is generally used as a measure of
antifreeze activity of the various AF(G)Ps. Among the
AF(G)Ps mentioned above, at the same protein concentration,
DAFP1 has the greatest antifreeze activity (i.e., producing the
highest TH), followed by AFGP1−5, and then AFGP8. Despite
large differences in their structures and antifreeze activities, all
the AF(G)Ps share remarkable capabilities for binding to
specific ice crystal faces and modifying the ice crystal habits
within the thermal hysteresis gap, representing a paradigmatic
case of controlling crystal growth.4,5
Controlling the shape and size of crystals is central to many
practical processes like pharmaceutical, food, materials, and
chemical manufacturing since the shape and size can have a
great impact on the chemical and physical properties.6−9 For
example, milling is commonly used in manufacturing active
pharmaceutical ingredients to reduce the particle size and
ensure homogeneity, but it costs energy, causes localized
heating, makes dusts, and can result in various defects in
crystals.9 Thus, the use of additives holds promise for processes
requiring control of crystal growth. Though the detailed
mechanism of how additives work is not yet fully understood,
substantial efforts have been directed toward the identification
and design of new additives. However, the molecular
recognition phenomena are generally limited to the cases of
inorganic salts, carbohydrates, amino acids, and benzene ring
containing compounds. Moreover, the known additives, except
for a few inorganic salts (e.g., sodium chloride), are all limited
to molecules having similar structures to the crystal substances
of interest and are only effective at concentrations of 2−20 wt
%.8,10,11 In the cases of inorganic salts, the controls of the
nucleation and/or crystal growth are based on ionic−ionic
interactions. For example, in shell biomineralization, shell
proteins control shell crystal growth by ionic interactions using
a relatively large amount (usually about 1:10 in molar
ratio).12,13
Proteins and/or peptides are known to play an amazing role
in both living organisms and the inanimate world to control the
growth of minerals and produce new forms of solids with
different properties.12−15 It has been reported that AFPs can
inhibit the growth of clathrate hydrates, a class of ice-like
crystalline solids.16 More recently, the molecular recognition
repertoire of AFPs has been shown to include non-ice-like
crystals, such as 5-methyluridine, and interestingly, the
distances between the hydroxyl oxygen atoms on the putative
ice-binding sites of AFPs closely match those between the
hydroxyl oxygen atoms on the fast growth faces of ice as well as
5-methyluridine.17 However, the effects of AFPs on clathrate
hydrates and nucleoside crystals are not directly related to their
antifreeze activities and the required dosages for the control of
nucleoside crystal growth are significantly less than those for ice
growth control.17,18
The structural compatibility between AF(G)Ps and the fast
growth faces of ice prompted us to explore their potential use
as agents to control crystal growth of non-ice-like crystalline
solids. We chose methyl α-D-mannopyranoside (MDM), a
representative compound in the family of pyranose sugars and
their derivatives for multiple reasons. MDM has wide industrial
applications, such as in the synthesis of resins, plastics, and
explosives.19,20 Moreover, MDM tends to crystallize from its
melt in large blocks with a high percent of twin defects, an
unwelcome crystal habit, which is unsuitable for X-ray
diffraction. Thus, far no effective additives for control of size
and shape of MDM crystal growth are known. Furthermore, the
exposed hydroxyls on the fast growth faces of MDM crystals
have a repeat distance which is similar to that of the hydrogen
bonding residues present in the AF(G)Ps, making them
promising candidates as additives for the control of MDM
crystal growth (Figure 2).
We made use of three different AF(G)Ps, DAFP1, AFGP1−
5, and AFGP8 with descending antifreeze activity, as additives
to control MDM crystal growth. We demonstrate for the first
time that the AF(G)Ps can inhibit the crystal growth and the
recrystallization of MDM and the effectiveness is related to
Figure 1. Structures of antifreeze biomolecules. (A) The structure of
the repeat unit of antifreeze glycoproteins (AFGPs). (B) A model
structure of beetle antifreeze protein isoform 1 from Dendroides
canadensis (DAFP1). The distances in the structures indicate the
periodicities.
Figure 2. Periodicities of the hydroxyl oxygen atoms on the growing
faces of methyl α-D-mannopyranoside (MDM) crystals. (A) The
hydroxyl oxygen atoms (O5) show repeat distances of 9.263 Å on the
(001) face along a axis. (B) The hydroxyl oxygen atoms (O3) have
repeat distances of 9.978 Å on the (010) face along c axis. (C) The
hydroxyl oxygen atoms (O2) have repeat distances of 9.369 Å on the
face of (100) along b axis.
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their antifreeze activity. It is also the first report of AF(G)Ps
controlling the growth and inhibiting recrystallization of non-
ice carbohydrate crystals. Significantly, the effective amounts of
AF(G)Ps for MDM recrystallization and crystal growth control
can be very small and the additive/MDM molar ratio was
shown to be as low as 10−7. The success of this new
methodology will have a great impact in further expansion of
the molecular recognition repertoire of AF(G)Ps, and the
results thus will greatly expand the potential applications of
AF(G)Ps in industry.
■ EXPERIMENTAL SECTION
Materials. The disaccharide, 2-acetamido-2-deoxy-3-O-(β-D-galac-
topyranosyl)-D-galactose, also called β-galactosyl (1 → 3)-α-N-
acetylgalactosamine, was purchased from Santa Cruz Biotechnology
(San Diego, CA). Lens culinaris lectin or agglutinin (LCA) was
purchased from Aniara (West Chester, OH 45069). All other
chemicals were purchased from Sigma-Aldrich (St. Louis, MO) at
ACS grade or better and used without additional purification, unless
otherwise indicated. All of the aqueous solutions were prepared using
Milli-Q water produced from a Synergy water system (Millipore) with
a minimum resistivity of 18 MΩ·cm. All the sample solutions were
filtered through 0.1 μm filters before use unless otherwise indicated.
National Scientific glass sample vials, 8 mL, were used for
crystallization. All glassware and stir bars were cleaned in a KOH/2-
propanol bath and rinsed with distilled water. After soaking in 1 M
HCl for 24 h and rinsing with distilled water, the glassware and stir
bars were further cleaned using RBS35 (Pierce), a surface-active
detergent. After rinsing with distilled water and then with deionized
water, the glassware and stir bars were air-dried at room temperature.
Synthesis of Methyl α-D-Mannopyranoside (MDM). DMSO
(10 mL) and methanol (500 mL) were added to a reaction vessel
containing 50 g of D-mannose. The mixture was refluxed overnight and
then stirred at room temperature for 1 day. The solids were filtered off,
dissolved in hot ethanol, and then allowed to crystallize as pure MDM.
Solution NMR Spectroscopy. 1H NMR spectra were recorded at
298 K on a 500 MHz Bruker NMR spectrometer. Chemical shifts (δ)
are reported in parts per million (ppm) relative to residual solvent
[D2O (TSP), δ 4.81, D2O (DSS), 4.40]. Multiplicities are given as s
(singlet), d (doublet), m (multiplet). Proton-decoupled 13C NMR
spectra were recorded at 125.8 MHz (13C). The 13C chemical shifts are
reported relative to CDCl3 (δ 77.2 ppm). The
1H and 13C NMR
spectra of the pure MDM are shown in Figures S1 and S2 (Supporting
Information).
Liquid Chromatography Electrospray Ionization-Mass Spec-
trometry (LC-ESI-MS). LC-ESI-MS data were collected on a Waters
LCT Premier XE time-of-flight instrument controlled by MassLynx 4.1
software. MDM samples were dissolved in methanol and infused using
direct loop injection from a Waters Acquity UPLC into the multimode
ionization source. The solvent was 50/50 (v/v) MeOH/MeCN (LC-
MS grade, VWR Scientific). The lock mass standard for accurate mass
determination was leucine enkephalin (Sigma L9133). LC-MS: the
calculated mass [(C7H14O6) + Na]
+ was 217.07 and observed at
217.07 m/z with an isotope pattern consistent with C, H, O
incorporation (Figure S3, Supporting Information).
Antifreeze Biomolecule Preparation. AFGP1−5 and AFGP8
were isolated from 5% trichloroacetic acid (TCA) supernatants of the
blood serum of the Antarctic toothfish Dissostichus mawsoni. The TCA
soluble AFGPs were further purified using HR-100 column
chromatography (2.5 × 130 cm) with a 25 mM ammonium
bicarbonate buffer. The fractions were lyophilized to remove the
volatile buffer. The separation of the AFGP1−5 group from the
smaller AFGP8 was verified by gel electrophoresis. MALDI-TOF mass
spectrometry gave a value of 2670 Da for AFGP8. The larger isoforms
of the AFGP1−5 fraction are not resolved with MALDI-TOF MS but
their molecular weights are known from previous studies involving
ultracentrifugation. The AFGPs were weighed on an Ohaus Voyager
Pro analytical precision balance (Parsippany, NJ) and were dissolved
in water.
DAFP-1 was expressed and purified as described previously.21 The
purified DAFP-1 was characterized using SDS-PAGE gel electro-
phoresis, MALDI-TOF mass spectrometer, circular dichroism (CD)
spectrometry, and differential scanning calorimetry (DSC), respec-
tively, as previously described22 and the identity of DAFP1 was
confirmed. The concentration of stock DAFP-1 solution was
determined using a Cary 100 Bio UV−vis spectroscopy (Varian)
and the extinction coefficient of 5.47 × 103 M−1 cm−1 at 280 nm was
used.23
The denatured DAFP-1 was made by reducing all its disulfide bonds
by a method previously reported.24 Briefly, DAFP1 (∼1 mM) was
incubated in 0.10 M sodium citrate, pH 3.0, and 15.0 mM tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) at 60 °C for 30 min.
The denatured DAFP1 was purified using ÄKTA Purifier 10 (GE
Healthcare) with a Sephacryl S-100 gel filtration column (GE
Healthcare).
Thermal Hysteresis Measurements. Freezing and melting
points were determined in aqueous AF(G)P samples using a Clifton
nanolitre osmometer (Clifton Technical Physics) following the
protocol of Cziko et al. 2006.25 The instrument was calibrated with
distilled water (0 mOsm) and a 1000 mOsm NaCl standard (Opti-
mole, Wescor Inc.). Samples were suspended in heavy immersion oil
in each of the 6 wells in the Clifton Nanoliter sample holder. They
were cooled until frozen and then slowly warmed until a single ice
crystal (approximately 10 μm) slowly melted while observed at 200×.
This temperature was taken as the melting point or equilibrium
freezing point. Following determination of the melting point, a 10 μm
single ice crystal was slowly cooled to 0.05 °C below the melting point
held for 1 min and then cooled to approximately 0.2 °C below the
melting point and held for 5 min. They were then cooled at 0.074 °C
per minute until sudden rapid growth was observed, and this value was
taken as the freezing point. Melting and freezing point determinations
for each individual were repeated twice per sample well in five separate
wells. The thermal hysteresis, the difference between the melting point
and the freezing point, represents the antifreeze activity.
Crystallization of MDM from the Aqueous Solution. Methyl
α-D-mannopyranoside (MDM) was previously crystallized only from
ethanol solutions.26 Here we found that MDM can be crystallized
directly from its aqueous solution. Thus, the AF(G)P and control
compounds were added directly to the aqueous MDM. Briefly, on day
1, 20 μL of water, AF(G)Ps, 2-acetamido-2-deoxy-3-O-(β-D-
galactopyranosyl)-D-galactose (Gal1-β-3GalNAc), and Lens culinaris
lectin or agglutinin (LCA) solutions of different concentrations were
added separately into each sample vial containing 2 mL of 515 mM
MDM. The final MDM concentration was 510 mM in each vial and
the resulting additive/MDM molar ratios were 20 × 10−5 (denatured
DAFP1/MDM), 3 × 10−7 (DAFP1/MDM), 2.0 × 10−4 (AFGP1−5/
MDM), 2.2 × 10−4 (AFGP8/MDM), 8.0 × 10−4 [Gal1-β-3GalNAc/
MDM], and 5.4 × 10−4 (LCA/MDM), respectively. The vials (8 mL,
National Scientific) were gently swirled after the additions and
remained uncovered and allowed to slowly evaporate at room
temperature. At least three weights were recorded everyday (i.e., at
least every 8 h) until all the liquid in the vials evaporated. The
experiments were repeated five times. Sample results are listed in
Table S1 (Supporting Information). The average sizes of the final
MDM crystals in each vial were determined using weight analysis and
the ratios of the average sizes of the final crystals of MDM in the
absence and presence of the AF(G)Ps are listed in Table 2. Optical
micrographs of the crystals that formed upon evaporation of the liquid
were taken with a DS-Fi2 color camera attached to a Nikon SMZ-1000
microscope.
Effect of Additives on Nascent MDM Crystals. The
crystallization of MDM in the absence of additives was reproducible
with respect to the sizes and shapes of the crystals. Thus, the same
criterion was used in the habit study in the presence of each of the
AF(G)Ps and controls. When the seed MDM crystals were first
observed under the microscope, DAFP-1, AFGP1−5 and AFGP8 were
added to the vials to final concentrations of 1.53, 102, and 112.2 μM,
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respectively. After incubation with the additives the induced habit
changes by AF(G)Ps were able to be terminated by removing the
mother liquor from the vials washing the crystals with ice-cold water
three times and transferring them into new vials containing the same
amount of fresh saturated MDM. Upon completion of crystallization,
the crystal habit was the same as those obtained in the absence of the
AF(G)P additives and from MDM solutions in the presence of the
control compound. Optical micrographs of the crystals were taken as
described above.
Crystallization Kinetics. The crystallization kinetics were
estimated based on the rate of crystal mass increase in each sample
vial. All liquid in a vial was collected and transferred to a closed cap vial
and the weight of the vial or the weight of the vial with crystals was
determined with an Oham Discovery semi micro analytical balance.
The liquid in the capped vial was then quickly transferred back to the
vial containing the crystals and the crystallization continued until the
next weight measure. Three vials were used for each additive and the
controls. The average weight values are reported.
Single Crystal X-ray Diffraction. Crystals without any additives
were sent to X-ray crystallography laboratory at UCSD for analysis. A
colorless crystal was mounted on a Cryoloop with Paratone-N oil and
data were collected at 125 K with a Bruker APEX II CCD using Cu K
alpha radiation. Data corrected for absorption with SADABS and
structure solved by direct methods. All non-hydrogen atoms were
refined anisotropically by full matrix least-squares on F2. Hydrogen
atoms of hydroxyl groups were found from Fourier difference maps
and were refined with O−H distance of 0.86 (0.01) Å and 1.20 Ueq of
parent O atoms. All other hydrogen atoms were placed in calculated
positions with appropriate riding parameters. Additional information
on data collection parameters are given in Table 1. The crystallo-
graphic data of MDM was deposited in the Cambridge Database
(CCDC) and the CCDC deposit number is 985875.
Twin Defect Determination. The ratios of twin defects of the
crystal samples were estimated by partitioned extinction under a
polarizing microscope (Nikon SMZ-1000 microscope with a DS-Fi2
color camera). At least 5 pieces were cut from one sample and the
diffraction patterns were determined at the Beckman Institute of
California Institute of Technology using a Bruker APEXII four circle
diffractometer with a SMART 1000 CCD detector using Mo radiation
from a sealed-tube X-ray generator both equipped with an Oxford
Cryosystems crystal cooling system. The twin defects were confirmed
by twin-lattice quasi-symmetry (TLQS).
Solid-State NMR Spectroscopy. Approximately 120 mg of solids
were gently ground using mortar and pestle and packed in a 4 mm
wide ZrO2 rotor with a Kel-F cap.
13C cross polarized magic angle
spinning (CP MAS) solid-state NMR spectra were recorded at 298 K
at 75.47 MHz (13C) on a 300 MHz Bruker spectrometer using a 4 mm
broadband MAS probe with proton broadband decoupler. Spinning
frequency of 10 kHz, CP contact time of 1.5 ms, and a 60 s delay were
utilized.
MALDI-TOF Mass Spectrometry. MDM crystals were quickly
washed with 1:1 (v:v) cold water−ethanol at ∼0 °C in order to
remove any potential nonspecific additives bound to solids. Each
resulting sample was lyophilized. MALDI-TOF mass spectra were
obtained on a PerSeptive Biosystems/Voyager-DE MALDI-TOF mass
spectrometer at the Stanford PAN facility. Calibrations of the mass
spectrometer against external mass standards were carried out before
sample analyses. The matrix, sinapinic acid, was prepared as a saturated
solution in 1:1 (v:v) water:acetonitrile with 0.1% trifluoroacetic acid. A
Ziptip C18 resin (Millipore) was used to desalt the mass sample. The
sample was dissolved in doubly distilled water−TFA at pH 3.00. 0.5
μL of the sample solution was mixed with an equal volume of the
matrix solution in a sample plate and air-dried before analysis.
Fourier Transform Infrared (FT-IR) Spectroscopy. FT-IR
attenuated total reflectance (ATR) spectra were collected on a Nicolet
iS5 FT-IR spectrometer (Thermo Fischer Scientific Inc., Waltham,
MA) equipped with an iD5 ATR accessory. The IR frequencies were
recorded in cm−1, and the spectra were measured in a spectral range
from 4000 to 200 cm−1.
■ RESULTS AND DISCUSSION
Structural Compatibility. The crystals of methyl α-D-
mannopyranoside (MDM) were obtained by slow evaporation
of their aqueous solutions at room temperature in the air. The
resulting MDM crystals appear as a few colorless blocks with
overlaps and about 75% having twin defects (Table S1,
Supporting Information). The structure of the MDM crystals
were determined using single-crystal X-ray diffraction and the
crystallographic parameters are listed in Table 1. The crystal
structures of MDM obtained in this study are in very good
agreement with those published previously27 but with an
improved resolution. The growing faces of MDM crystal
include (001), (010), and (100) and all these faces have
hydroxyl oxygen groups in a periodic manner: on the (010)
face, the hydroxyl oxygen atoms (O3) have the repeat distance
of 9.263 Å (or 9.978 Å) along a (or c) axis; on the (001) face,
the hydroxyl oxygen atoms (O5) have the repeat distances of
9.263 Å (or 9.369 Å) along a (or b) axis; while the hydroxyl
oxygen atoms (O2) are on the face of (100) with the repeat
distance of 9.369 Å (or 9.978 Å) along b (or c) axis (Figure 2).
The hydroxyl groups in the O-linked disaccharide on each
threonine residue in the AFGP repeat unit of Ala-Ala-Thr have
been modeled to bind to the prism planes of hexagonal ice
presumably through hydrogen bonding.28 As reported by NMR
studies, the length of the 3-mer repeat in the polyproline II
backbone of AFGPs is 9.31 Å,29 which is about twice the repeat
spacing in ice along the a-axis. The periodicity of the AFGP
backbone, 9.31 Å, matches the repeat distance between the
hydroxyl oxygen atoms, 9.263 or 9.369 Å, on the growing faces
of MDM crystal surprisingly well (Figures 1A and 2A,C).
Moreover, the average distance between the hydroxyl groups in
the conserved threonine residues in adjacent repeat loops of
DAFP-1 is 4.74 Å deduced from homology modeling,22 twice
which is 9.48 Å and compatible with all the three possible
repeat hydroxyl oxygen spacings, 9.263, 9.369, or 9.978 Å, on
the growing faces of MDM crystals (Figures 1B and 2). This
remarkable similarity in repeat spacings between AF(G)Ps and
MDM crystal faces led us to examine the effect of AF(G)Ps on
MDM crystal growth.
Effect of AF(G)Ps on MDM Recrystallization Inhibition
and Crystal Growth. On the basis of the apparent structural
compatibility between MDM and the AF(G)Ps, we selected
Table 1. Crystallographic Data for Methyl α-D-
Mannopyranoside (MDM)
parameter MDM
formula C7H14O6
formula weight 194.18
temperature (K) 125(2)
crystal system orthorhombic
space group P212121
a/Å 9.2633(2)
b/Å 9.3690(2)
c/Å 9.9779(2)
α = β = γ 90°
cell volume/Å3 865.96(3)
calc density/g cm−3 1.489
Z 4
data/restraints/parameters 1543/2/131
final R indices for I > 2σ(I) R1 = 0.0232
wR2 = 0.0685
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two Antarctic fish AFGPs AFGP8 and AFGP1−5 with 4 and
approximately 15−65 glycotripeptide repeats, respectively, and
a beetle AFP from D. canadensis, DAFP1, as potential additives
to control the crystal growth of MDM. The crystallization of
MDM was carried out using a wide range of additive
concentrations, and the AF(G)Ps prevented the growth of
large MDM crystals resulting in smaller MDM crystals with
improved quality. Although the direct addition of these
AF(G)Ps at the various concentrations had little effect on the
crystallization induction time of MDM, both DAFP1 and
AFGP1−5 remarkably delayed the time for completion of
crystallization (refer to Figure 4). The extent of the delay
depended on the additive/MDM molar ratio; the greater the
molar ratio, the later the completion of crystallization (Table
S1, Supporting Information). A certain additive/MDM molar
ratio, referred as to the critical ratio, is needed to efficiently
inhibit small MDM crystals from growing into large ones (or
inhibit MDM recrystallization). Here, the critical ratios of
DAFP1/MDM, AFGP1−5/MDM, and AFGP8/MDM were
estimated to be 3.0 × 10−7, 2.0 × 10−6, and 2.2 × 10−4,
respectively. At ratios higher than the critical ratios, DAFP1
ranks as the most effective followed by, AFGP1−5, and then
AFGP8 in inhibiting the growth of large MDM crystals. As
indicated previously, in the absence of antifreeze additives,
MDM crystals appear as a large overlapping block with twin
defects (Figure 3A). In contrast, in the presence of AFGP8 and
AFGP1−5, approximately 30 and 60% of the final MDM
crystals appeared as smaller triangular shaped blocks,
respectively (Figure 3B,C). Remarkably, with DAFP1, all the
final MDM crystals appeared as even smaller grains (Figure
3D). No apparent morphology changes in the MDM crystals
obtained in the presence of the AF(G)Ps were observed,
suggesting that the adsorption of the additives and the kinetics
of the adsorption both affect MDM crystal growth.6 Moreover,
the twin defect percentage in the MDM crystals dropped from
approximately 75% (in the absence of additives) to 40, 15, and
less than 5%, in the presence of AFGP8, AFGP1−5, and
DAFP1, respectively. The quality of the MDM crystals obtained
with the AF(G)Ps are greatly improved and much more
suitable for single X-ray crystallography analysis in comparison
to those without additives.
In the absence of additives or in the presence of any of the
controls, the crystallization of MDM started during day 12 and
was complete by day 14 (Figure 4). With AFGP1−5 and
DAFP1 (at the critical ratios of additive/MDM), the
crystallization of MDM still started during day 12, but was
prolonged, from 14 days to 14.5 and 16 days, respectively
(Figure 4). Once the crystals of MDM appear, AFGP8 at its
critical ratio can inhibit the further growth of MDM crystals
until day 3, but has little effect on prolonging the crystallization
process of MDM (Figure 4).
Generally, additives may affect crystal growth by modifying
crystal habit and/or affecting nucleation.6,8,17 To understand
how AF(G)Ps influence MDM crystal growth, AFGP8,
AFGP1−5, DAFP1 were also added to the saturated MDM
aqueous solutions in the presence of MDM seed crystals and
the additive/MDM ratios were at the critical ratios. MDM
crystals continue to grow in all the sample vials, while the final
MDM crystals appeared to have better defined shapes with
smaller sizes (Figure S4, Supporting Information). Moreover,
the crystal quality for X-ray diffraction was also improved
compared to those obtained in the absence of the AF(G)Ps
(Table S1, Supporting Information). The overall effectiveness
of AF(G)Ps as additives in inhibiting the recrystallization and
crystal growth of MDM is well correlated with their antifreeze
activities (Figure 5). AF(G)Ps are well-known for inhibiting ice
recrystallization and modifying ice morphology (e.g., flat-round
shaped polycrystalline ice can be modified to hexagonally
shaped single crystal ice by AF[G]Ps).2,30,31 The effect of
AF(G)Ps on MDM are notably similar to their effect on ice.
To further demonstrate that the effects of AF(G)Ps on
MDM crystal growth are related to the structural compatibility
between MDM and the additive, we selected three control
compounds and performed the crystallization of MDM in their
presence. 2-acetamido-2-deoxy-O-(β-D-galactopyranosyl)-D-gal-
actose (Gal1-β-3GalNAc) is the disaccharide unit attached to
threonine residues in the AFGPs but by itself shows no
antifreeze activity. Denatured DAFP1 with a disrupted tertiary
Figure 3. Optical micrographs of the MDM crystals: in the absence of
additives (A), in the presence of AFGP8 (B), AFGP1−5 (C) and
DAFP1 (D), respectively. The length of the scale bars is 1 mm. The
zoom-in views (150%) of the isolated MDM crystals in (C) and (D)
are shown in the corresponding insets.
Figure 4. Crystallization kinetics of MDM in the presence of AFGP8
(green), AFGP1−5 (blue), and DAFP1 (red), respectively. The data
of the control (black) are the average data of MDM in the absence and
presence of the three controls, Gal1-β-3GalNAc, LCA, and denatured
DAFP1. The error bars represent the standard deviation from at least
three measurements.
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structure also retains no antifreeze activity. A 46 kDa
carbohydrate binding protein, Lens culinaris lectin (LCA),
that binds specifically to α-D-mannose and α-D-glucose,32,33 was
also used. As expected, none of these compounds inhibited the
formation of large MDM crystals or affected the crystallization
rate of MDM (Figure S5, Supporting Information). Though
LCA is a lectin that binds to some carbohydrates, it cannot
recognize MDM and therefore does not affect the crystal-
lization of MDM. The results in the presence of Gal1-β-
3GalNAc indicates that the molecular recognition is between
the intact AFGPs and the MDM crystal, rather than between
the isolated disaccharide and MDM suggesting that the
structural compatibility involves the spacings of the dis-
accharides and their hydroxyl groups as determined by the
repeat spacing of the threonines in the peptide backbone.
Moreover, the results in the presence of denatured DAFP1
strongly suggest that the structural compatibility between
DAFP1 and MDM crystal faces must exist.
Crystal habit is determined by the relative growth rates of
specific crystal faces.6 In the absence of additives, the growth
rates of (001), (010) and (100) faces of MDM crystals are
similar, resulting in the final overlapping block shape of MDM
crystals. The altered crystal habit and size of MDM crystals in
the presence of AF(G)Ps indicate that AF(G)Ps may selectively
adsorb onto one or more of these faces by hydrogen-bonding
interactions between the hydroxyl groups in the O-linked
disaccharides in AFGPs or in the conserved threonines in
DAFP1 and the hydroxyl oxygen atoms in the growing faces of
MDM crystal (Figures 1 and 2). The characteristics of useful
additives for crystallization include those that have a high
selectivity for the fast growing crystal face(s), form a lattice
match and bind reversibly.34 Here, the AF(G)Ps are shown to
be excellent additives for MDM crystallization that are effective
at very low concentrations. In addition to this characteristic,
AF(G)Ps have another feature that may account for their
superior ability in controlling the crystallization of MDM,
which is, they have distinct hydrophilic and hydrophobic faces
positioned on opposite sides of the molecule. The hydrophilic
face of AF(G)Ps may interact with the MDM lattice sites
through hydrogen-bonding interactions, while the hydrophobic
faces may be exposed to the bulk solution and play a role in
rejecting incoming MDM molecules from joining the crystal
lattice until the desorption of AF(G)Ps occurs.
The MDM crystals formed in the presence of the additives as
well as with the controls were analyzed using single crystal X-
ray diffraction, and no new forms were identified. The
hydrogen bonding networks of the resulting MDM crystals
were also examined using solid-state NMR spectroscopy and
attenuated total reflectance infrared spectroscopy (ATR-IR).
The 13C cross-polarization magic angle spinning (CP-MAS)
NMR and ATR-IR spectra of the MDM crystals with altered
habits obtained in the presence of AF(G)Ps were almost
identical to those of the MDM crystals obtained in the absence
of AF(G)Ps and with the control compounds. The
representative 13C CP-MAS NMR and ATR-IR spectra are
shown in Figures 6 and S6 (Supporting Information),
respectively. These results further support the absence of any
new crystal forms of MDM as well as the absence of amorphous
precipitates and indicate that the obtained smaller triangular
shaped MDM crystals are just habit modification by the
AF(G)Ps.
MALDI-TOF mass spectrometry was utilized to investigate
the existence of possible interactions between the additives and
MDM crystals. The mass results of AF(G)Ps alone indicated
that the molecular weights (MWs) of AFGP8, AFGP1−5, and
DAFP1 are 2670, 8968, and 9009 Da. Although the MW of
AFGP1−5 gave only the 9009 Da isoform the larger isoforms
are most likely also involved in the inhibition process even
though they fail to show up in the MALDI spectra. Moreover,
the molecular weights of AFGPs determined in this work are
close to the reported values using sedimentation equilibrium
Figure 5. Thermal hysteresis (TH) (or antifreeze) activities of
DAFP1, AFGP1−5, and AFGP8 measured using nanoliter. The error
bars represent the standard deviation from at least three measure-
ments.
Figure 6. Representative CPMAS 13C NMR spectra of the MDM
crystals in the absence and presence of AF(G)Ps. The CPMAS 13C
NMR spectra of MDM crystals in the absence of AF(G)Ps (A) and in
the presence of DAFP1 (B). The insets show the details of the peak
with an asterisk and the habits of the MDM crystals are shown at the
right upper corner of each panel (the length of the scale bars is 1 mm).
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centrifugation.1 The mass spectra of the resulting MDM crystal
samples in the presence of these additives show the peaks of
AFGP1−5, AFGP8, and DAFP1, respectively, suggesting
adsorption of the AF(G)Ps to MDM crystals (Figure 7). In
contrast, no peaks of denatured DAFP1, Gal1-β-3GalNAc, or
LCA were observed in the mass spectra of the MDM crystal
samples in the presence of these control compounds (data not
shown).
It is suggested that the adsorption of AF(G)Ps onto the fast
growing faces of MDM crystal delays the growth of MDM
crystal or directly inhibits the MDM nuclei at the early stage,
while increasing the supersaturation of the MDM solution
resulting in the formation of more nuclei of MDM at a later
time. As a result, smaller sized MDM crystals grow rather than
large overlapping ones. Moreover, the results suggest that the
effects of AF(G)Ps on MDM crystallization may be similar to
their known effects on ice crystals, though significantly much
smaller amounts of AF(G)Ps are needed to control the MDM
crystal growth compared to ice.2−4,35,36 Notably, the efficacy of
the AF(G)Ps on control of MDM crystallization has been
shown to be related to their antifreeze activity, the first
demonstration that the efficacy of the control of crystal growth
correlates to their antifreeze activity.16−18
Size Changes of MDM by AF(G)Ps: Theoretical
Aspects. Crystal sizes are generally determined by the rates
of nucleation and crystal growth.6 Since the concentrations of
the AF(G)Ps are extremely low in contrast to that of MDM, we
can assume that the diffusion of MDM molecules from its bulk
solution to nuclei and/or crystal faces remains a constant and
the crystallization process is a homogeneous nucleation case.
Thus, in the absence of AF(G)Ps, the final crystal sizes of
MDM depend only on the rate of nucleation. The number of
nuclei formed per unit time per unit volume, J, can be expressed
as
= −ΔJ Ae G RT( / ) (1)
where R is the gas constant, T is the experimental temperature,
and A is the Arrhenius constant for the system, and ΔG is the
critical free energy change for the nucleation of MDM.
The MDM crystallization induction time without any
additives is t. The presence of the AF(G)Ps may inhibit the
nucleation of MDM until the additives are fully consumed by
the nuclei. Such process increases the degree of supersaturation
at the time t + Δt, resulting in a different number of nuclei
formed per unit time per unit volume, J′, and a different critical
free energy change, ΔG′.
′ = −Δ ′J Ae G RT( / ) (2)
The total final masses of MDM crystals should be equal in
the absence and presence of additives:
= + Δ ′ ′ ′tVJS t t V J S( ) (3)
where V is the volume of the MDM solution at the induction
time t, V′ is the volume of the MDM solution with the
AF(G)Ps at the time t + Δt, and S and S′ are the average sizes
of the final crystals of MDM in the absence and presence of
additives. According to the experimental observations, we can
assume Δt ≪ t and (t +Δt) V′ = t V. In the absence of
additives, the crystal growth of MDM starts at t and at t + Δt,
the newly formed nuclei may join into the early grown crystals
and finally lead to the overlapped block shaped MDM crystals
with high percent of twin defects.
Substituting eqs 1 and 2 into eq 3 and rearranging, we obtain
′ = ′ = −ΔΔS S J J e/ / G RT( / ) (4)
where ΔΔG = ΔG − ΔG′, the critical free energy change
differences of the MDM nucleation in the absence and presence
of the additives.
By substituting the ratio of the average sizes of the final
MDM crystals in the absence and presence of each AF(G)P (S/
S′) into eq 4, the ΔΔG can be calculated and the results are
consistent with the effectiveness of the additives (Table 2).
Moreover, these values are close to those of the ice nucleation
in the presence of AF(G)Ps,35 suggesting similar interactions
are involved in the molecular recognition of MDM by the
AF(G)Ps.
■ CONCLUSION
Although the structures and crystal faces of ice and MDM are
clearly very distinct: hexagonal ice Ih (the most common and
abundant crystal form of ice) belongs to the space group of
P63/mmc with a = b = 4.52 Å and c = 7.36 Å;
37 MDM crystals
belong to the space group of P212121 with a = 9.263 Å, b =
9.369 Å, and c = 9.978 Å, the periodicities in ice Ih and MDM
have similarities. In MDM crystals, the periodicity in the
direction of a (9.263 Å) is very close to that of b (9.369 Å) and
both of these periodicities are approximately double the
periodicity in the direction of a (4.52 × 2 = 9.04 Å) in ice
Ih. Both ice Ih and MDM have exposed hydroxyl groups on
one or more of their crystal faces whose periodicities are
approximately n × 4.7 Å (n = 1, 2, 3, ...), matching the
periodicities in the AF(G)Ps (Figure 1). The adsorption of
AF(G)Ps to MDM crystals and their effect on its crystallization
suggest a noteworthy structural compatibility between the
AF(G)Ps and the fast growing faces of MDM crystal.
Moreover, the theoretical analysis suggested that the molecular
recognition of MDM by AF(G)Ps are similar to that of ice by
AF(G)Ps. It is possible that the molecular recognition
repertoire of AF(G)Ps may involve other crystal compounds,
Figure 7. MALDI-TOF mass spectra of the achieved MDM crystals in
the presence of AF(G)Ps. The peaks of AF(G)Ps were observed: (A)
AFGP8 (m/z = 2670.7), (B) DAFP1 (m/z = 8968.6), and (C)
AFGP1−5 (m/z).
Table 2. Estimated Difference of the Critical Free Energy
Change of the MDM Nucleation in the Absence and
Presence of the AF(G)Ps (ΔΔG)
AFGP8 AFGP1−5 DAFP1
S/S′ ( × 103)a 0.2 ± 0.0 2.2 ± 0.5 34.3 ± 0.5
ΔΔG (kJ/mol)b −13.2 ± 0.0 −19.0 ± 0.2 −25.9 ± 0.0
aS/S′ is the ratio of the average sizes of the final crystals of MDM in
the absence and presence of the AF(G)Ps. bΔΔG was estimated using
eq 4, where R = 8.314 J·mol−1·K−1 and T = 298 K.
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which could be shown by using this methodology we have
described. Searches for a structural compatibility between
AF(G)Ps and the fast growing crystal faces could result in the
expansion of the potential applications of AF(G)Ps in a wide
range of industries.
This finding also suggests a new possibility for addressing the
details of the mechanisms of the AF(G)Ps adsorption inhibition
of ice crystal growth. Physical methods that are available for the
mechanistic study of AF(G)P-ice interactions, however, are
very limited in ability to resolve these contradictions, largely
due to the instability of ice crystals and the difficulties of
handling ice crystals with specific crystal faces under well-
controlled low-temperatures. MDM crystals are stable at room
temperature and the study of AF(G)P-MDM interactions does
not require specialized equipment. AF(G)Ps are known for
their ability to inhibit ice growth and recrystallization.1 It is still
a matter of debate whether AF(G)Ps bind reversibly or
irreversibly to ice surfaces.38−42 The theoretical analysis on the
size changes of MDM by the AF(G)Ps suggests that the
molecular recognitions between AF(G)Ps and MDM and
between AF(G)Ps and ice are similar. Thus, MDM might be
used as a potential model to study the mechanism of AF(G)P
action on ice. Comprising such structurally diverse classes of
proteins and ligands, the detailed mechanism of AF(G)P-ligand
action is, however, very complex and needs further study.
The discovery of the molecular recognition between
AF(G)Ps and MDM crystals, based on their structural
compatibility, may be more than a coincidence. In fact, the
evolutionary origins of some AFPs are lectins. For examples,
type II fish AFPs are homologues of the carbohydrate
recognition domain of Ca2+ dependent C-type lectins43 and
the origin of type III fish AFP is sialic acid synthase.44
Moreover, winter rye AFPs are homologues of Chitinase and
glucanase that bind to polysaccharides,45 and carrot AFP is a
homologue of polygalacturonase inhibitor.2 AFGPs have
evolved from trypsinogen like protease.46 Though the origin
of DAFP1 is currently unknown, DAFP1 has been demon-
strated to recognize MDM in this work and certain nucleo-
sides.17 Furthermore, known lectins can usually bind to more
than one ligand.47 Thus, it should not come as a surprise if
AF(G)Ps can recognize other carbohydrates and/or the origin
of DAFP1 might be related to a carbohydrate binding protein.
Efficient control of the crystallization of carbohydrates is
crucial in sugar and related food and pharmaceutical industries.
Industrial additives for sugar crystallization are usually
compounds with similar structures to the target sugar crystals
and a concentration of 2−20% (w/w) is required for
effects.48,49 The required molar ratio of AF(G)Ps for effects
on MDM crystallization can be as low as 10−7. The high efficacy
in controlling the size and shape of carbohydrate crystals and
the high stability of AF(G)Ps suggests possible applications of
the AF(G)Ps as useful additives and/or scaffolds for designing
novel additives in sugar and related food and pharmaceutical
industries.
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